Acusphere (Acusphere) Change In Receivables : $0.00 Mil (TTM As of Sep. 2008)

View and export this data going back to 2003. Start your Free Trial

What is Acusphere Change In Receivables?

Acusphere's change in receivables for the quarter that ended in Sep. 2008 was $0.00 Mil. It means Acusphere's Accounts Receivable stayed the same from Jun. 2008 to Sep. 2008 .

Acusphere's change in receivables for the fiscal year that ended in Dec. 2007 was $0.00 Mil. It means Acusphere's Accounts Receivable stayed the same from Dec. 2006 to Dec. 2007 .

Acusphere's Accounts Receivable for the quarter that ended in Sep. 2008 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Acusphere's Days Sales Outstanding for the three months ended in Sep. 2008 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Acusphere's liquidation value for the three months ended in Sep. 2008 was $-29.02 Mil.

Acusphere Change In Receivables Historical Data

The historical data trend for Acusphere's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acusphere Change In Receivables Chart

Acusphere Annual Data

Trend

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Change In Receivables

Get a 7-Day Free Trial

Acusphere Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Acusphere Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Acusphere (OTCPK:ACUS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Acusphere's Days Sales Outstanding for the quarter that ended in Sep. 2008 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0.339	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Acusphere's accounts receivable are only considered to be worth 75% of book value:

Acusphere's liquidation value for the quarter that ended in Sep. 2008 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4.112	-	33.133	+	0.75 * 0	+	0.5 * 0
=	-29.02

Acusphere Change In Receivables Related Terms

Thank you for viewing the detailed overview of Acusphere's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Acusphere (Acusphere) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acusphere Inc (OTCPK:ACUS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421

Website

http://www.acusphere.com

Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.

Executives

Martyn D Greenacre	director	41 MOORES ROAD, FRAZER PA 19355
Garen G Bohlin	director	C/O PRAECIS PHARMACEUTICALS INC, 830 WINTER STREET, WALTHAM MA 02451
Sandra L Fenwick	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Frederick W Ahlholm	officer: VP Finance	C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451
John F Thero	other: Former Senior VP/CFO	C/O AMARIN PHARMA, INC., 1430 ROUTE 6, BEDMINSTER NJ 07921
Kate Mitchell	director	950 TOWER LANE, STE 700, FOSTER CITY CA 94404
Bank Of America Corp /de/	10 percent owner	BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE NC 28255
Bank Of America Na	10 percent owner	100 N. TRYON STREET, CHARLOTTE NC 28255
Nb Holdings Corp	10 percent owner	100 NORTH TRYON STREET, CHARLOTTE NC 28255
Terrance Mcguire	director	C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154

Acusphere (Acusphere) Headlines

No Headlines